+1,040.6%
NBIS vs THC
+61.6%
+978.9%
-58.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.1% | -2.1% | -3.0% | -4.7% |
| 7D | +8.3% | 0.0% | +8.3% | +8.3% |
| 30D | +18.1% | +1.5% | +16.5% | +17.7% |
| 3M | +7.8% | +59.9% | -52.1% | -5.5% |
| 6M | +136.6% | +11.0% | +125.6% | +133.9% |
| YTD | +172.5% | +32.6% | +139.9% | +150.9% |
| 1Y | +144.3% | +37.4% | +106.9% | +121.5% |
| All | +1,040.6% | +61.6% | +978.9% | +790.5% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling